Our company specializes in developing molecular diagnostics equipment. We have developed a proprietary new method for noninvasively monitoring the immune system by measuring gene expression in patients peripheral blood. The technology offers the potential to decrease healthcare costs and significantly improve the quality of life for patients with a variety of life-threatening or life-altering, immune-mediated diseases.

Please quote eSources UK when contacting us.